X @The Economist
Novo Nordisk(US:NVO) The Economist·2025-12-17 12:20Novo Nordisk wants to grow its direct channels, which currently account for a tenth of its weight-loss jab prescriptions in America. The drugmaker is revising its pricing, too https://t.co/IuSb2NdVsW ...